financetom
Business
financetom
/
Business
/
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing
Mar 19, 2024 8:59 AM

11:39 AM EDT, 03/19/2024 (MT Newswires) -- Christian Todd Nichols, SVP, Chief Commercial Officer, on March 18, 2024, sold 10,417 shares in Alkermes ( ALKS ) for $292,740. Following the Form 4 filing with the SEC, Nichols has control over a total of 65,911 shares of the company, with 65,911 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1520262/000112760224010395/xslF345X03/form4.xml

Price: 27.50, Change: -0.03, Percent Change: -0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digital Brands Q1 Loss Narrows, Revenue Declines; Shares Down
Digital Brands Q1 Loss Narrows, Revenue Declines; Shares Down
May 20, 2024
11:49 AM EDT, 05/20/2024 (MT Newswires) -- Digital Brands Group ( DBGI ) shares were down more than 13% in recent Monday trading following its Q1 results. Earlier, the company reported a Q1 net loss of $0.46 per diluted share, narrowing from a net loss of $27.48 per share a year ago. Revenue for the quarter ended March 31 was...
Looking At Workday's Recent Unusual Options Activity
Looking At Workday's Recent Unusual Options Activity
May 20, 2024
Benzinga's options scanner has just identified more than 12 option transactions on Workday , with a cumulative value of $389,110. Concurrently, our algorithms picked up 3 puts, worth a total of 129,730. Projected Price Targets Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $220.0 to $290.0 for Workday over...
Update: Dyne Shares Rise After Trial Data of DYNE-101, DYNE-251 Showed Improvements in Functional Endpoints, Favorable Safety Profiles
Update: Dyne Shares Rise After Trial Data of DYNE-101, DYNE-251 Showed Improvements in Functional Endpoints, Favorable Safety Profiles
May 20, 2024
11:22 AM EDT, 05/20/2024 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.) Dyne Therapeutics ( DYN ) shares rose by nearly 25% after the company said Monday that new data from its ongoing phase 1/2 trials of DYNE-101 in patients with myotonic dystrophy type 1 and DYNE-251 in patients with Duchenne muscular dystrophy...
Looking At Vistra's Recent Unusual Options Activity
Looking At Vistra's Recent Unusual Options Activity
May 20, 2024
Financial giants have made a conspicuous bearish move on Vistra ( VST ). Our analysis of options history for Vistra ( VST ) revealed 16 unusual trades. Delving into the details, we found 12% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $241,195, and 11...
Copyright 2023-2026 - www.financetom.com All Rights Reserved